These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11131269)

  • 1. Association of human hepatocyte growth factor with hemodialysis hypotension.
    Nishimura M; Ushiyama M; Maruyama Y; Mabuchi H; Takahashi H; Yoshimura M
    Hypertens Res; 2000 Nov; 23(6):581-6. PubMed ID: 11131269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced production of nitric oxide may be involved in acute hypotension during maintenance hemodialysis.
    Nishimura M; Takahashi H; Maruyama K; Ohtsuka K; Nanbu A; Hara K; Yoshimura M
    Am J Kidney Dis; 1998 May; 31(5):809-17. PubMed ID: 9590191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of nitric oxide in haemodialysis hypotension.
    Nishimura M; Takahashi H; Yoshimura M
    Acta Physiol Scand; 2000 Jan; 168(1):181-6. PubMed ID: 10691798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased nitric oxide production in hypotensive hemodialysis patients.
    Lin SH; Chu P; Yu FC; Diang LK; Lin YF
    ASAIO J; 1996; 42(5):M895-9. PubMed ID: 8945014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodialysis hypotension: interaction of inhibitors, iNOS, and the interdialytic period.
    Kang ES; Tevlin MT; Wang YB; Chiang TM; Cardenas R; Myers LK; Acchiardo SR
    Am J Med Sci; 1999 Jan; 317(1):9-21. PubMed ID: 9892267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory markers and hepatocyte growth factor in sustained hemodialysis hypotension.
    Lee CT; Hsu CY; Lam KK; Lin CR; Chen JB
    Artif Organs; 2005 Dec; 29(12):980-3. PubMed ID: 16305655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum concentrations of human hepatocyte growth factor in proliferative diabetic retinopathy.
    Nishimura M; Nakano K; Ushiyama M; Nanbu A; Ohtsuka K; Takahashi H; Yoshimura M
    J Clin Endocrinol Metab; 1998 Jan; 83(1):195-8. PubMed ID: 9435440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible sequestration of nitric oxide by hemoglobin during hemodialysis in end-stage renal disease.
    Kang ES; Miles DE; Tevlin MT; Cates TB; Acchiardo SR
    Am J Med Sci; 2001 Feb; 321(2):113-23. PubMed ID: 11217813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum hepatocyte growth factor as a possible indicator of vascular lesions.
    Nishimura M; Ushiyama M; Ohtsuka K; Nishida M; Inoue N; Matsumuro A; Mineo T; Yoshimura M
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2475-80. PubMed ID: 10404823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased plasma adrenomedullin levels in hemodialysis patients with sustained hypotension.
    Cases A; Esforzado N; Lario S; Vera M; Lopez-Pedret J; Rivera-Fillat F; Jimenez W
    Kidney Int; 2000 Feb; 57(2):664-70. PubMed ID: 10652045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased nitric oxide production in patients with hypotension during hemodialysis.
    Yokokawa K; Mankus R; Saklayen MG; Kohno M; Yasunari K; Minami M; Kano H; Horio T; Takeda T; Mandel AK
    Ann Intern Med; 1995 Jul; 123(1):35-7. PubMed ID: 7762912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypotension during hemodialysis: role for nitric oxide.
    Kang ES; Acchiardo SR; Wang YB; Tevlin MT; Hughes T; Cardoso S
    Am J Med Sci; 1997 Mar; 313(3):138-46. PubMed ID: 9075430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased vitreous concentrations of human hepatocyte growth factor in proliferative diabetic retinopathy.
    Nishimura M; Ikeda T; Ushiyama M; Nanbu A; Kinoshita S; Yoshimura M
    J Clin Endocrinol Metab; 1999 Feb; 84(2):659-62. PubMed ID: 10022434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradialytic hypotension: beyond hemodynamics.
    Hajal J; Joubran N; Sleilaty G; Chacra D; Saliba Y; Assaad S; Chelala D; Fares N
    Physiol Res; 2019 Oct; 68(5):793-805. PubMed ID: 31424249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of serum osmotic changes in symptomatic hypotension during short hemodialysis.
    Shaldon S; Deschodt G; Beau MC; Ramperez P; Mion C
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():184-8. PubMed ID: 756043
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypotension during hemodialysis results from an impairment of arteriolar tone and left ventricular function.
    Nette RW; van den Dorpel MA; Krepel HP; Ie EH; van den Meiracker AH; Poldermans D; Weimar W; Zietse R
    Clin Nephrol; 2005 Apr; 63(4):276-83. PubMed ID: 15847254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylene blue, a nitric oxide inhibitor, prevents haemodialysis hypotension.
    Peer G; Itzhakov E; Wollman Y; Chernihovsky T; Grosskopf I; Segev D; Silverberg D; Blum M; Schwartz D; Iaina A
    Nephrol Dial Transplant; 2001 Jul; 16(7):1436-41. PubMed ID: 11427637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic hypotension in hemodialysis patients: role of functional vascular changes and vasodilator agents.
    Coll E; Larrousse M; de la Sierra A; Collado S; Jiménez W; Cases A
    Clin Nephrol; 2008 Feb; 69(2):114-20. PubMed ID: 18365352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midodrine treatment for patients with hemodialysis hypotension.
    Flynn JJ; Mitchell MC; Caruso FS; McElligott MA
    Clin Nephrol; 1996 Apr; 45(4):261-7. PubMed ID: 8861803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.